Exploring Novel and Emerging Prophylactic Therapies for Hereditary Angioedema
hosted byPrime Education, LLCExploring Novel and Emerging Prophylactic Therapies for Hereditary Angioedema is organized by Prime Education, LLC.
Release Date: August 30, 2023
Expiration Date: August 29, 2024
Description:
Join two expert faculty in this engaging evidence-based discussion focused on the prophylactic treatment of hereditary angioedema (HAE).
View a custom whiteboard animation to gain a deeper understanding of the pathophysiology of the disease and the targets of novel and emerging prophylactic therapies.
The latest clinical data for these agents, as well as strategies for individualizing management plans, will also be explored.
Learning Objectives:
• Differentiate the inflammatory pathways and mediators involved in the pathogenesis of HAE
• Evaluate new and emerging long-term prophylactic therapies for HAE based on their mechanisms of action and routes of administration, as well as the latest clinical efficacy and safety data
• Develop individualized management plans for patients with HAE that integrate patient- and disease-specific factors into personalized treatment decisions for prophylaxis
Agenda:
• HAE Disease Pathogenesis and Molecular Treatment Targets
• Latest Clinical Data for Novel and Emerging Long-Term Prophylactic Therapies for HAE
• Individualizing HAE Prophylactic Therapy Selection to Improve Patient Outcomes and Adherence
